200 related articles for article (PubMed ID: 12475611)
1. Emerging role of endothelin-1 in tumor angiogenesis.
Bagnato A; Spinella F
Trends Endocrinol Metab; 2003 Jan; 14(1):44-50. PubMed ID: 12475611
[TBL] [Abstract][Full Text] [Related]
2. Role of endothelin-1 in neovascularization of ovarian carcinoma.
Salani D; Di Castro V; Nicotra MR; Rosanò L; Tecce R; Venuti A; Natali PG; Bagnato A
Am J Pathol; 2000 Nov; 157(5):1537-47. PubMed ID: 11073813
[TBL] [Abstract][Full Text] [Related]
3. Endothelin B receptor deficiency predisposes to pulmonary edema formation via increased lung vascular endothelial cell growth factor expression.
Carpenter T; Schomberg S; Steudel W; Ozimek J; Colvin K; Stenmark K; Ivy DD
Circ Res; 2003 Sep; 93(5):456-63. PubMed ID: 12919946
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of tumor angiogenesis by distinct ErbB homo- and heterodimers.
Yen L; Benlimame N; Nie ZR; Xiao D; Wang T; Al Moustafa AE; Esumi H; Milanini J; Hynes NE; Pages G; Alaoui-Jamali MA
Mol Biol Cell; 2002 Nov; 13(11):4029-44. PubMed ID: 12429844
[TBL] [Abstract][Full Text] [Related]
5. Endothelin-1 and angiogenesis in cancer.
Knowles J; Loizidou M; Taylor I
Curr Vasc Pharmacol; 2005 Oct; 3(4):309-14. PubMed ID: 16248773
[TBL] [Abstract][Full Text] [Related]
6. Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies.
Shannon AM; Bouchier-Hayes DJ; Condron CM; Toomey D
Cancer Treat Rev; 2003 Aug; 29(4):297-307. PubMed ID: 12927570
[TBL] [Abstract][Full Text] [Related]
7. A radicicol derivative, KF58333, inhibits expression of hypoxia-inducible factor-1alpha and vascular endothelial growth factor, angiogenesis and growth of human breast cancer xenografts.
Kurebayashi J; Otsuki T; Kurosumi M; Soga S; Akinaga S; Sonoo H
Jpn J Cancer Res; 2001 Dec; 92(12):1342-51. PubMed ID: 11749701
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia.
Marti HJ; Bernaudin M; Bellail A; Schoch H; Euler M; Petit E; Risau W
Am J Pathol; 2000 Mar; 156(3):965-76. PubMed ID: 10702412
[TBL] [Abstract][Full Text] [Related]
9. Cerebral angiogenesis and expression of VEGF after subarachnoid hemorrhage (SAH) in rats.
Jośko J
Brain Res; 2003 Aug; 981(1-2):58-69. PubMed ID: 12885426
[TBL] [Abstract][Full Text] [Related]
10. Regulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by an insulin-like growth factor-I receptor autocrine loop in human pancreatic cancer.
Stoeltzing O; Liu W; Reinmuth N; Fan F; Parikh AA; Bucana CD; Evans DB; Semenza GL; Ellis LM
Am J Pathol; 2003 Sep; 163(3):1001-11. PubMed ID: 12937141
[TBL] [Abstract][Full Text] [Related]
11. Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors.
Petit AM; Rak J; Hung MC; Rockwell P; Goldstein N; Fendly B; Kerbel RS
Am J Pathol; 1997 Dec; 151(6):1523-30. PubMed ID: 9403702
[TBL] [Abstract][Full Text] [Related]
12. Is HIF-1 alpha a valid therapeutic target?
Pili R; Donehower RC
J Natl Cancer Inst; 2003 Apr; 95(7):498-9. PubMed ID: 12671009
[No Abstract] [Full Text] [Related]
13. Antitumor efficacy of FK228, a novel histone deacetylase inhibitor, depends on the effect on expression of angiogenesis factors.
Sasakawa Y; Naoe Y; Noto T; Inoue T; Sasakawa T; Matsuo M; Manda T; Mutoh S
Biochem Pharmacol; 2003 Sep; 66(6):897-906. PubMed ID: 12963476
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors.
Yamakawa M; Liu LX; Date T; Belanger AJ; Vincent KA; Akita GY; Kuriyama T; Cheng SH; Gregory RJ; Jiang C
Circ Res; 2003 Oct; 93(7):664-73. PubMed ID: 12958144
[TBL] [Abstract][Full Text] [Related]
15. Chronic blockade of endothelin receptors improves ischemia-induced angiogenesis in rat hindlimbs through activation of vascular endothelial growth factor-no pathway.
Iglarz M; Silvestre JS; Duriez M; Henrion D; Lévy BI
Arterioscler Thromb Vasc Biol; 2001 Oct; 21(10):1598-603. PubMed ID: 11597932
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor (VEGF) modulation by targeting hypoxia-inducible factor-1alpha--> hypoxia response element--> VEGF cascade differentially regulates vascular response and growth rate in tumors.
Tsuzuki Y; Fukumura D; Oosthuyse B; Koike C; Carmeliet P; Jain RK
Cancer Res; 2000 Nov; 60(22):6248-52. PubMed ID: 11103778
[TBL] [Abstract][Full Text] [Related]
17. Vasoactive peptides modulate vascular endothelial cell growth factor production and endothelial cell proliferation and invasion.
Pedram A; Razandi M; Hu RM; Levin ER
J Biol Chem; 1997 Jul; 272(27):17097-103. PubMed ID: 9202027
[TBL] [Abstract][Full Text] [Related]
18. Coexpression of hypoxia-inducible factor 1-alpha and vascular endothelial growth factor in Wilms' tumor.
Karth J; Ferrer FA; Perlman E; Hanrahan C; Simons JW; Gearhart JP; Rodriguez R
J Pediatr Surg; 2000 Dec; 35(12):1749-53. PubMed ID: 11101729
[TBL] [Abstract][Full Text] [Related]
19. Clinical and experimental evidence of prostaglandin E1-induced angiogenesis in the myocardium of patients with ischemic heart disease.
Mehrabi MR; Serbecic N; Tamaddon F; Kaun C; Huber K; Pacher R; Wild T; Mall G; Wojta J; Glogar HD
Cardiovasc Res; 2002 Nov; 56(2):214-24. PubMed ID: 12393092
[TBL] [Abstract][Full Text] [Related]
20. Constitutive upregulation of hypoxia-inducible factor-1alpha mRNA occurring in highly metastatic lung carcinoma cells leads to vascular endothelial growth factor overexpression upon hypoxic exposure.
Koshikawa N; Iyozumi A; Gassmann M; Takenaga K
Oncogene; 2003 Oct; 22(43):6717-24. PubMed ID: 14555985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
